FEATURED ARTICLE

Are Investigational New Drug Trials in India A Positive Sign For Healthcare · Cliniexperts

Are Investigational New Drug Trials in India A Positive Sign For Healthcare On June 1st, 2021, the Indian Government announced the waiver of requiring prior India bridging clinical trials to be conducted for the US and UK-based vaccines for the novel COVID-19. This move comes in the midst of immense pressure faced by the Government

Introduction


Clinical trials are essential to discover new treatments for any disease as they aid in testing the safety and effectiveness of various drugs and devices. Since 2018, we at CliniExperts, in line with the ethical and regulatory compliance required to undertake such trials, have been paving the way for clinical research in India. We offer clinical research services for various product lines, including Drugs, Medical Devices, and IVD, Biologicals, and Consumer Claims

page main image

Experience and Expertise in Regulatory Compliance: Trust CliniExperts Research Services for Your Clinical Trial Needs

With a strong regulatory track record and numerous accreditations/approvals from regulatory agencies, CliniExperts Research Services provides therapeutic, regulatory, and operational expertise to consistently solve your challenges.

MISSION

CliniExperts aims to become the preferred CRO partner for pharmaceutical and biotechnology companies across the world, employing quality excellence, timely delivery, cost-effectiveness, scientific competence, and recognition. Our mission is to emerge as a leading organisation in contract research services by focusing on improving performance and higher accuracy of clinical trial data.By adopting a professional approach, effective time management strategies, innovative ideas, technological advancements and customer-centric entrepreneurship we are moving strength to strength.

VALUES

With the outbreak of many new diseases and lack of treatment for the same, at CliniExperts,we believe in creating therapeutic products for them that should undergo a clinical evaluation to ensure high quality and ethical standards. Our value system supports and ensures transparency, integrity, productivity, respect and quality support, all with compassion and passion. We don't think it's enough to be good, it's time to be excellent in every aspect of the research process.

CliniExperts aims to become a global best-in-class contract research organisation offering comprehensive clinical development program services for drugs and devices while delivering key outcomes to pharmaceutical, generics and biotechnology companies within a defined timeframe and with excellence.

Drug


Drug

Testing new drugs is a cumbersome process. It is costly and involves following a lot of procedures and compliances. This is why you need the right partner to undertake a clinical drug trial. With CliniExperts, you can conduct successful clinical trials for various drug categories in India, such as New Drugs, Fixed-Dose Combinations, Investigational New Drugs, and Subsequent New Drugs.


Know More..
Medical Devices and IVD


Medical Devices and IVD

In India, a clinical investigation for medical devices is mainly required for Class B, Class C, and Class D devices. However, in certain cases, it might also be required for Class A devices. We, at CliniExperts, are focused on conducting high-quality trials, and provide a range of services. We support the sponsor to launch their own Medical Devices and in-vitro diagnostics (IVD) in a hassle-free manner.


Know More..
Biologicals cell


Biologicals

Biologicals are considered to be new drugs in India, and cannot be launched without conducting a successful clinical trial. Blood Products, DNA Products, Stem cells & cell-based products, and Vaccines fall under the category of Biologicals. CliniExperts Research Services can assist you in fast-forwarding your clinical trial for biologicals in India, by offering support for various approvals and grant permissions.


Know More..
Consumer Claims refund


Consumer Claims

Certifications always help to build trust and brand value among customers. But, it is a complicated process and can take a lot of time. We, at CliniExperts, provide various clinical trial services for food, food supplement, beverages, cosmetics, and cosmeceutical products to simplify the process. Our expertise includes GI Analysis, SPF, UVA/UVB Analysis, Nutritional or Health Benefits Analysis, Immunity Claims and Anti-Ageing Claims, etc


Know More..
page main image

Scientific Excellence

With ever-changing regulatory scenarios and our expertise across a wide range of therapeutic areas, we can make a tangible difference in your clinical development research. In an increasingly competitive marketplace and ever-changing regulatory scenarios, our expertise can make a tangible difference in your clinical development program.

  • Biosimilar and Biologics: Biosimilar and Biologics are different from small molecules. They require intricate micro-level planning at every level. We, at CliniExperts, consider every small yet significant issue carefully such as window period breaks up of the dosing schedule, cold chain breaks, drug administration and storage at home in case if trial involved drug administration daily etc. We can give you an edge to proactively plan, predict, and manage various kinds of operational issues at the beginning itself. It can reduce costs and help you manage operations smoothly.

Operational Excellence

As treatment demands shift and new diseases emerge, the research process has come under immense pressure. At CliniExperts, our goal is to ensure long-term sustainability by achieving operational excellence through continuous improvements, fostering a holistic environment, and cultivating a collaborative workforce led by committed leadership to accomplish our objectives.
quote icon


It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using their infancy. Various versions have.



Deepak
Deepak Bidani
MMTC Pvt. Ltd.
research group icon 3

Driving Innovation and Sustainability in Clinical Research: CRO's Commitment to Operational Excellence and Collaborative Leadership

Looking for a sustainable and reliable partner in clinical research? CliniExperts is committed to achieving operational excellence through continuous improvements, a holistic environment, and a collaborative workforce. Trust us to rise to the challenge and help you stay ahead of the curve in the face of evolving treatment demands and emerging diseases.

Expert Articles

Biologicals |
Clinical Trials
CDSCO Guidelines for Biological Clinical Trials in India (NDCT Rules 2019)
CDSCO Guidelines for Biological Clinical Trials in India (NDCT Rules 2019) define a structured regulatory pathway for evaluating biologics through phased human studies. The framework ensures safety, quality, and efficacy through strict documentation, ethical approval, GCP compliance, and scientific review. It supports safe development of vaccines, gene therapies, and other biologics before market authorization in
Medical Devices
WPC Import License for Wireless Devices in India
WPC import license India is a mandatory regulatory approval required for importing wireless and radio-frequency-enabled devices into the Indian market under the WPC framework. Understanding WPC Compliance in India The Wireless Planning and Coordination Wing (WPC) operates under the Department of Telecommunications in India. It regulates wireless communication equipment and radio frequency usage. Manufacturers and
Drug
Investigational New Drug (IND) Application in India: Requirements & Proces
The Investigational New Drug application process in India is a structured regulatory framework that enables safe initiation of human clinical trials. It requires submission of preclinical and supporting scientific data for a detailed review by authorities. The evaluation focuses on safety, quality, and ethical compliance under the Second Schedule of New Drugs and Clinical Trial
Drug
Subsequent New Drug (SND): Regulatory Pathway & Clinical Trial Requirements
A subsequent New Drug (SND) refers to an approved Drug that is modified and requires fresh regulatory approval before marketing. The process includes defined application cases, detailed evaluation, and sometimes clinical trial support. Regulatory authorities check safety, quality, and effectiveness at each step. Clinical trial guidelines ensure ethical conduct and reliable data generation, helping to

*All the above fields are mandatory
contact us 2
Enquire now